The role of integrin α2 in cell and matrix therapy that improves perfusion, viability and function of infarcted myocardium
Ali Ahmadi(Shahrekord University of Medical Sciences), Erik J. Suuronen(University of Ottawa), Jennifer M. Renaud(University of Ottawa), L. Mesana(University of Ottawa), Jean N. DaSilva(Centre Hospitalier de l’Université de Montréal), Drew Kuraitis(University of Ottawa), Rob Beanlands(University of Ottawa), Branka Vulesevic(Jewish General Hospital), Robert A. deKemp(University of Ottawa), Darryl R. Davis(University of Ottawa), Marc Ruel(University of Ottawa), Emily Manthorp(University of Ottawa), Stephanie Thorn(University of Ottawa), Thierry Mesana(University of Ottawa), Hadi Toeg(University of Ottawa), Brian McNeill(University of Ottawa), Myra Kordos(University of Ottawa)
Cited by 39
Related Papers
Predictive Factors, Management, and Clinical Outcomes of Coronary Obstruction Following Transcatheter Aortic Valve Implantation
|Journal of the American College of Cardiology|2013|643
Impaired Myocardial Flow Reserve on Rubidium-82 Positron Emission Tomography Imaging Predicts Adverse Outcomes in Patients Assessed for Myocardial Ischemia
|Journal of the American College of Cardiology|2011|602
Anatomic Versus Physiologic Assessment of Coronary Artery Disease
|Journal of the American College of Cardiology|2013|563
The Use of <sup>18</sup>F-FDG PET in the Diagnosis of Cardiac Sarcoidosis: A Systematic Review and Metaanalysis Including the Ontario Experience
|Journal of Nuclear Medicine|2012|512